Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
3362 | 2000 | 42.7 | 76% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
144 | 3 | ENDOCRINOLOGY & METABOLISM//PITUITARY ADENOMA//GROWTH HORMONE | 64198 |
1175 | 2 | PROLACTIN//PROLACTIN RECEPTOR//MACROPROLACTIN | 9333 |
3362 | 1 | PROLACTIN RECEPTOR//PROLACTIN//INSERM U344 | 2000 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PROLACTIN RECEPTOR | authKW | 1115255 | 8% | 46% | 159 |
2 | PROLACTIN | authKW | 843913 | 27% | 10% | 548 |
3 | INSERM U344 | address | 183516 | 1% | 52% | 23 |
4 | PHOSPHORYLATED PROLACTIN | authKW | 127213 | 1% | 83% | 10 |
5 | PROLACTIN ANTAGONIST | authKW | 106861 | 0% | 100% | 7 |
6 | PROLACTIN RECEPTOR ANTAGONIST | authKW | 93502 | 0% | 88% | 7 |
7 | S179D PROLACTIN | authKW | 91595 | 0% | 100% | 6 |
8 | HYPERPROLACTINEMIA | authKW | 88963 | 3% | 10% | 60 |
9 | STELLAR CHANCE S 513 | address | 78509 | 0% | 86% | 6 |
10 | EQUIPE PHYSIOPATHOL HORMONES PRL GH | address | 63606 | 0% | 83% | 5 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Endocrinology & Metabolism | 13937 | 33% | 0% | 650 |
2 | Rheumatology | 2476 | 7% | 0% | 133 |
3 | Oncology | 1110 | 14% | 0% | 280 |
4 | Cell Biology | 949 | 13% | 0% | 258 |
5 | Immunology | 800 | 11% | 0% | 225 |
6 | Medicine, Research & Experimental | 480 | 7% | 0% | 138 |
7 | Reproductive Biology | 411 | 3% | 0% | 63 |
8 | Biochemistry & Molecular Biology | 267 | 14% | 0% | 282 |
9 | Andrology | 129 | 1% | 0% | 11 |
10 | Physiology | 115 | 4% | 0% | 73 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | INSERM U344 | 183516 | 1% | 52% | 23 |
2 | STELLAR CHANCE S 513 | 78509 | 0% | 86% | 6 |
3 | EQUIPE PHYSIOPATHOL HORMONES PRL GH | 63606 | 0% | 83% | 5 |
4 | MALAD RA GYNECOL | 61064 | 0% | 100% | 4 |
5 | SECT MOL ENDOCRINOL | 54381 | 1% | 25% | 14 |
6 | QFB | 45798 | 0% | 100% | 3 |
7 | U344 | 44845 | 1% | 24% | 12 |
8 | MOL CELLULAR ENDOCRINOL SECT | 41549 | 0% | 39% | 7 |
9 | EQUIPE PRL GH TUMEURS | 34347 | 0% | 75% | 3 |
10 | UNIT 808 | 34347 | 0% | 75% | 3 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MOLECULAR AND CELLULAR ENDOCRINOLOGY | 12367 | 4% | 1% | 84 |
2 | MOLECULAR ENDOCRINOLOGY | 10696 | 3% | 1% | 63 |
3 | ENDOCRINOLOGY | 9972 | 6% | 1% | 128 |
4 | JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA | 6344 | 1% | 3% | 16 |
5 | LUPUS | 4658 | 2% | 1% | 34 |
6 | JOURNAL OF MOLECULAR ENDOCRINOLOGY | 4527 | 1% | 1% | 25 |
7 | JOURNAL OF ENDOCRINOLOGY | 3654 | 2% | 1% | 45 |
8 | PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE | 2703 | 1% | 1% | 27 |
9 | ENDOCRINE | 2105 | 1% | 1% | 21 |
10 | PROSTATE | 1589 | 1% | 0% | 22 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PROLACTIN RECEPTOR | 1115255 | 8% | 46% | 159 | Search PROLACTIN+RECEPTOR | Search PROLACTIN+RECEPTOR |
2 | PROLACTIN | 843913 | 27% | 10% | 548 | Search PROLACTIN | Search PROLACTIN |
3 | PHOSPHORYLATED PROLACTIN | 127213 | 1% | 83% | 10 | Search PHOSPHORYLATED+PROLACTIN | Search PHOSPHORYLATED+PROLACTIN |
4 | PROLACTIN ANTAGONIST | 106861 | 0% | 100% | 7 | Search PROLACTIN+ANTAGONIST | Search PROLACTIN+ANTAGONIST |
5 | PROLACTIN RECEPTOR ANTAGONIST | 93502 | 0% | 88% | 7 | Search PROLACTIN+RECEPTOR+ANTAGONIST | Search PROLACTIN+RECEPTOR+ANTAGONIST |
6 | S179D PROLACTIN | 91595 | 0% | 100% | 6 | Search S179D+PROLACTIN | Search S179D+PROLACTIN |
7 | HYPERPROLACTINEMIA | 88963 | 3% | 10% | 60 | Search HYPERPROLACTINEMIA | Search HYPERPROLACTINEMIA |
8 | ANTI PROLACTIN AUTOANTIBODY | 48849 | 0% | 80% | 4 | Search ANTI+PROLACTIN+AUTOANTIBODY | Search ANTI+PROLACTIN+AUTOANTIBODY |
9 | NB2 CELLS | 46744 | 0% | 44% | 7 | Search NB2+CELLS | Search NB2+CELLS |
10 | G129R | 45798 | 0% | 100% | 3 | Search G129R | Search G129R |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | BOLE-FEYSOT, C , GOFFIN, V , EDERY, M , BINART, N , KELLY, PA , (1998) PROLACTIN (PRL) AND ITS RECEPTOR: ACTIONS, SIGNAL TRANSDUCTION PATHWAYS AND PHENOTYPES OBSERVED IN PRL RECEPTOR KNOCKOUT MICE.ENDOCRINE REVIEWS. VOL. 19. ISSUE 3. P. 225 -268 | 187 | 36% | 1004 |
2 | SHELLY, S , BOAZ, M , ORBACH, H , (2012) PROLACTIN AND AUTOIMMUNITY.AUTOIMMUNITY REVIEWS. VOL. 11. ISSUE 6-7. P. A465-A470 | 74 | 75% | 60 |
3 | BERNICHTEIN, S , TOURAINE, P , GOFFIN, V , (2010) NEW CONCEPTS IN PROLACTIN BIOLOGY.JOURNAL OF ENDOCRINOLOGY. VOL. 206. ISSUE 1. P. 1 -11 | 69 | 83% | 67 |
4 | GOFFIN, V , BERNICHTEIN, S , TOURAINE, P , KELLY, PA , (2005) DEVELOPMENT AND POTENTIAL CLINICAL USES OF HUMAN PROLACTIN RECEPTOR ANTAGONISTS.ENDOCRINE REVIEWS. VOL. 26. ISSUE 3. P. 400-422 | 93 | 64% | 116 |
5 | ORBACH, H , ZANDMAN-GODDARD, G , BOAZ, M , AGMON-LEVIN, N , AMITAL, H , SZEKANECZ, Z , SZUCS, G , ROVENSKY, J , KISS, E , DORIA, A , ET AL (2012) PROLACTIN AND AUTOIMMUNITY HYPERPROLACTINEMIA CORRELATES WITH SEROSITIS AND ANEMIA IN SLE PATIENTS.CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY. VOL. 42. ISSUE 2. P. 189-198 | 70 | 78% | 14 |
6 | COSTANZA, M , BINART, N , STEINMAN, L , PEDOTTI, R , (2015) PROLACTIN: A VERSATILE REGULATOR OF INFLAMMATION AND AUTOIMMUNE PATHOLOGY.AUTOIMMUNITY REVIEWS. VOL. 14. ISSUE 3. P. 223 -230 | 71 | 66% | 8 |
7 | BEN-JONATHAN, N , LAPENSEE, CR , LAPENSEE, EW , (2008) WHAT CAN WE LEARN FROM RODENTS ABOUT PROLACTIN IN HUMANS?.ENDOCRINE REVIEWS. VOL. 29. ISSUE 1. P. 1 -41 | 125 | 33% | 226 |
8 | GOFFIN, V , TOURAINE, P , (2015) THE PROLACTIN RECEPTOR AS A THERAPEUTIC TARGET IN HUMAN DISEASES: BROWSING NEW POTENTIAL INDICATIONS.EXPERT OPINION ON THERAPEUTIC TARGETS. VOL. 19. ISSUE 9. P. 1229 -1244 | 68 | 72% | 2 |
9 | DEVI, YS , HALPERIN, J , (2014) REPRODUCTIVE ACTIONS OF PROLACTIN MEDIATED THROUGH SHORT AND LONG RECEPTOR ISOFORMS.MOLECULAR AND CELLULAR ENDOCRINOLOGY. VOL. 382. ISSUE 1. P. 400-410 | 79 | 54% | 11 |
10 | CLEVENGER, CV , FURTH, PA , HANKINSON, SE , SCHULER, LA , (2003) THE ROLE OF PROLACTIN IN MAMMARY CARCINOMA.ENDOCRINE REVIEWS. VOL. 24. ISSUE 1. P. 1 -27 | 107 | 40% | 307 |
Classes with closest relation at Level 1 |